# Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction

> **NCT00755183** · PHASE2 · COMPLETED · sponsor: **ORA, Inc.** · enrollment: 60 (actual)

## Conditions studied

- Meibomian Gland Dysfunction

## Interventions

- **DRUG:** testosterone ophthalmic solution
- **DRUG:** vehicle of testosterone ophthalmic solution

## Key facts

- **NCT ID:** NCT00755183
- **Lead sponsor:** ORA, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2020-10-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00755183

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00755183, "Safety and Efficacy Study of a Testosterone Eye Drop for the Treatment of Meibomian Gland Dysfunction". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT00755183. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*